ICCR To Consider Regulatory Harmonization On Allergen Issues
This article was originally published in The Rose Sheet
At FDA’s June 2 public meeting to prepare for the eighth iteration of the International Cooperation on Cosmetics Regulation, the agency recapped accomplishments from ICCR-7 and outlined cosmetic regulatory topics to be addressed at ICCR-8. Allergens are up for discussion, as are trace materials.
You may also be interested in...
During a public preparatory meeting in advance of the ninth International Cooperation for Cosmetics Regulation summit, FDA Office of Cosmetics and Colors Director Linda Katz said that the topic of cosmetic product preservation will be included on the agenda for the first time. Animal-testing alternatives, allergens and trace impurities also are up for discussion, continuing regulators' work from last year on those topics.
Following the International Cooperation on Cosmetics Regulation’s eighth meeting in Ottawa, representatives from trade groups PCPC and CCTFA spoke with “The Rose Sheet” about ICCR’s progress to date and its growing influence on regulation within core member jurisdictions, as well as with other stakeholders around the world.
ICCR’s new centralized website provides access to documents on topics of interest and other information on the coalition. More news in brief.